Prelude Therapeutics Incorporated logo PRLD - Prelude Therapeutics Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 5
HOLD 1
SELL 2
STRONG
SELL
0
| PRICE TARGET: $8.00 DETAILS
HIGH: $8.00
LOW: $8.00
MEDIAN: $8.00
CONSENSUS: $8.00
UPSIDE: 72.41%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 4.6 5.6 6.5 0 0 4 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.4 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 4.2 5.6 6.5 0 0 4 3 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 13.6 18.0 21.7 25.8 28.8 31.6 29.5 29.5 27.4 30.3 26.3 25.0 21.8 25.9 22.9 21.3 22.8 25.2 22.7 22.4 16.5 14.6 15.3 9.8 8.5 8.8 5.5 5.0 5.0
SG&A Expenses 4.8 5.0 5.2 6.4 5.8 6.2 7.9 7.7 6.9 6.7 7.1 7.4 7.3 7.5 7.5 8.2 7.5 7.8 8.1 5.5 5.5 4.9 2.9 1.7 1.2 1.2 1.4 0.6 0.6
Other Expenses 0 0 0 0 0 0 0 0 0 0 (0.0) 0 0 (0.0) 0 0 0 (0.0) 0 0 0.0 0 0 0 0 0 0 0 0
Operating Expenses 18.4 23.0 26.9 32.2 34.6 37.8 37.4 37.2 34.3 37.0 33.4 32.4 29.1 33.4 30.4 29.5 30.3 33.0 30.8 27.9 22.0 19.4 18.1 11.4 9.7 10.1 6.9 5.4 5.4
Operating Income
Operating Income (14.2) (17.3) (20.4) (32.2) (34.6) (33.8) (34.4) (37.2) (34.3) (37.4) (33.4) (32.4) (29.1) (33.4) (30.4) (29.5) (30.3) (33.0) (30.8) (27.9) (22.0) (19.4) (18.1) (11.4) (9.7) (10.1) (6.9) (5.6) (5.6)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (10.0) (16.0) (19.3) (30.8) (31.6) (28.2) (31.9) (34.3) (31.0) (32.7) (30.3) (30.1) (27.4) (28.3) (29.6) (27.1) (29.2) (32.6) (30.4) (26.7) (21.8) (19.3) (18.0) (11.3) (9.6) (10.0) (6.8) (5.5) (5.5)
EBIT (10.4) (16.5) (19.7) (31.2) (32.1) (28.7) (32.3) (34.7) (31.4) (33.1) (30.6) (30.4) (27.7) (28.6) (30.0) (27.4) (29.5) (32.8) (30.7) (26.9) (22.0) (19.4) (18.1) (11.4) (9.7) (10.1) (6.9) (5.6) (5.6)
Income Before Tax (10.4) (16.5) (19.7) (31.2) (32.1) (28.7) (32.3) (34.7) (31.4) (33.1) (30.6) (30.4) (27.7) (28.6) (30.0) (27.4) (29.5) (32.8) (30.7) (26.9) (21.3) (19.2) (16.8) (11.4) (9.5) (10.0) (6.7) (5.4) (5.4)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (10.4) (16.5) (19.7) (31.2) (32.1) (28.7) (32.3) (34.7) (31.4) (33.1) (30.6) (30.4) (27.7) (28.6) (30.0) (27.4) (29.5) (32.8) (30.7) (26.9) (21.3) (19.2) (16.8) (11.4) (9.5) (10.0) (6.7) (5.4) (5.4)
Per Share Data
EPS (Basic) -0.13 -0.26 -0.26 -0.41 -0.42 -0.38 -0.43 -0.46 -0.42 -0.48 -0.45 -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 -0.51 -0.44 -0.30 -0.29 -0.31 -0.21 -3.43 -3.43
EPS (Diluted) -0.13 -0.26 -0.26 -0.41 -0.42 -0.38 -0.43 -0.46 -0.42 -0.48 -0.45 -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 -0.51 -0.44 -0.30 -0.29 -0.31 -0.21 -3.42 -3.42
Shares Outstanding 82.5 63.0 76.1 76.0 76.0 75.9 75.9 75.8 75.7 69.6 67.6 56.2 47.7 47.9 47.4 47.3 47.1 46.3 46.3 46.1 45.1 38.1 38.1 38.1 32.4 32.4 32.4 1.6 1.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 21.8 35.3 47.5 25.8 40.3 12.5 11.1 27.8 24.7 25.3 15.9 26.4 18.2 30.6 52.0 50.7 51.6 31.8 61.4 343.1 363.0 218.3 234.8 29.7 0 18.9 (15.6)
Short-Term Investments 59.8 68.0 7.4 47.5 58.8 121.1 142.5 152.0 177.2 207.6 214.6 228.5 154.1 171.1 172.0 195.6 214.6 259.4 259.4 0 0 0 0 0 0 0 31.2
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.0 2.5 3.4 0 3.3 2.3 2.8 2.9 0 2.7 4.4 (0.0) 0 2.7 0 0 0 0 0 0 0 2.5 3.3 0 0 0 0
Total Current Assets 84.6 105.7 58.3 76.9 102.4 135.9 156.4 182.7 205.4 235.6 234.9 260.2 175.3 204.4 226.9 248.6 270.0 295.1 325.9 344.6 365.0 220.8 238.1 30.7 0 20.2 15.6
Non-Current Assets
Property, Plant & Equipment 31.5 32.3 33.1 33.9 34.7 35.5 36.4 37.1 37.4 37.7 7.1 7 6.7 6.7 6.5 6.1 6.3 5.6 5.3 5.0 4.8 2.5 1.6 1.6 0 1.6 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3.5 3.3 3.3 4.2 4.2 4.2 4.4 4.4 4.3 4.3 16.5 13.4 16.3 9.4 9.0 4.4 4.4 4.3 (0.0) 0 0 0.3 0 0.5 0 0 (15.6)
Total Non-Current Assets 35.0 35.6 36.4 38.0 38.9 39.6 40.8 41.6 41.7 42.1 23.6 20.4 23.1 16.1 15.4 10.4 10.7 10.0 5.3 5.0 4.8 2.8 1.6 2.0 0 1.6 (15.6)
Total Assets 119.6 141.3 94.8 114.9 141.3 175.5 197.2 224.3 247.1 277.7 258.5 280.6 198.3 220.5 242.3 259.1 280.7 305.1 331.2 349.6 369.8 223.6 239.7 32.7 0 21.9 0
Current Liabilities
Account Payables 2.1 4.0 2.5 5.0 5.8 7.7 5.9 6.2 5.3 4.6 5.2 5.6 7.1 6.8 10.2 6.3 7.4 7.8 11.1 6.8 4.8 3.9 5.1 3.5 0 2.0 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 31.0 33.7 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.4 8.1 7.4 0.9 4.6 9.8 8.4 6.1 0.8 6.6 7.8 0.8 0.9 6.2 0.2 0.3 3.0 5.0 3.5 2.3 3.2 0.4 0.2 0 0 1.6 0
Total Current Liabilities 41.7 53.0 18.2 20.9 19.8 25.6 22.2 23.3 17.6 21.8 16.9 15.2 19.7 21.7 21.6 15.8 16.1 19.2 19.7 14.7 12.4 11.4 11.4 5.6 0 4.8 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 2.8 2.8 2.9 3.0 3.0 3.1 3.2 3.2 3.3 3.3 3.4 3.4 3.4 3.4 3.4 2.4 2.4 0 0 0 (0.0) 0.0 0.0 0.0 0 66.4 0
Total Non-Current Liabilities 17.7 19.7 18.0 18.2 18.3 18.4 18.6 18.7 18.7 18.7 3.4 3.4 3.4 3.4 3.4 2.4 2.8 0 0.3 0.5 0.8 0.0 0.0 0.0 0 66.4 0
Total Liabilities 59.5 72.7 36.2 39.1 38.1 44.1 40.8 42.0 36.4 40.6 20.3 18.6 23.0 25.1 24.9 18.2 18.9 19.2 20.0 15.2 13.3 11.4 11.4 5.7 0 71.3 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0
Retained Earnings (693.4) (683.1) (666.6) (646.9) (615.6) (583.6) (554.8) (522.6) (487.8) (456.4) (423.3) (392.7) (362.3) (334.6) (305.9) (276.0) (248.6) (219.1) (186.3) (155.6) (128.7) (107.4) (88.2) (71.4) 0 (50.5) 0
Accumulated Other Comprehensive Income (0.0) 0.0 0.0 (0.0) 0.0 0.0 0.2 (0.3) (0.2) 0.2 (0.6) (0.7) (0.4) (1.7) (2.4) (2.3) (2.3) (0.7) (0.2) 0 0 0 (239.7) 0 0 0 (22.7)
Total Stockholders' Equity 60.2 68.6 58.5 75.8 103.2 131.5 156.4 182.3 210.7 237.1 238.3 262.1 175.3 195.4 217.4 240.8 261.8 285.9 311.2 334.4 356.6 212.2 228.3 27.1 0 (49.4) 13.9
Total Liabilities & Equity 119.6 141.3 94.8 114.9 141.3 175.5 197.2 224.3 247.1 277.7 258.5 280.6 198.3 220.5 242.3 259.1 280.7 305.1 331.2 349.6 369.8 223.6 239.7 32.7 0 21.9 13.9
Debt Metrics
Total Debt 17.7 17.8 17.9 17.9 17.9 18.0 18.1 18.2 17.6 16.9 0.5 0.9 1.4 1.8 1.4 1.8 2.2 1.7 2.1 1.9 2.2 0 0 0.1 0 0.3 0
Net Debt (4.0) (17.5) (29.7) (7.8) (22.3) 5.6 7.0 (9.6) (7.1) (8.4) (15.4) (25.5) (16.8) (28.8) (50.6) (48.9) (49.4) (30.1) (59.3) (341.2) (360.7) (218.3) (234.8) (29.6) 0 (18.6) 15.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (10.4) (16.5) (19.7) (31.2) (32.1) (28.7) (32.3) (34.7) (31.4) (33.1) (30.6) (30.4) (27.7) (28.6) (30.0) (27.4) (29.5) (32.8) (30.7) (26.9) (21.3) (19.2) (16.8) (11.4) (9.5) (10.0) (6.7) (0.0) (0.0)
Depreciation & Amortization 0.4 0.3 0.4 0.4 0.4 0.5 (3.3) 0.5 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 2 1.8 2.4 3.8 3.8 3.8 12.0 6.1 5.5 5.9 6.7 6.7 6.3 5.8 6.4 6.0 6.8 5.8 7.0 4.2 3.9 3.1 1.5 0.6 0.4 0.3 0.3 0.0 0.0
Change in Working Capital (13.7) 37.1 (2.6) 0.7 (6.9) 4.3 (0.9) 6.1 (5.2) 3.7 (0.9) (4.3) (8.9) (0.8) 1.3 1.1 (0.7) (0.3) 0.9 2.2 0.8 1.1 2.6 1.7 (0.9) 1.1 0.7 (0.0) (0.0)
Other Non-Cash Items (0.0) 0.3 0.3 0.2 0.5 (0.6) (2.9) (0.9) (1.1) 0.6 0.5 0.1 (0.0) 0.3 1.4 1.5 1.2 1.4 0.7 0.3 0.3 0.0 0 0 0 0.0 0.0 (0.0) (0.0)
Operating Cash Flow (21.7) 23.1 (19.1) (26.1) (34.2) (20.7) (27.3) (23.1) (31.8) (23.6) (25.7) (27.7) (30.1) (22.9) (20.4) (18.5) (21.9) (25.7) (21.8) (19.9) (16.1) (14.8) (12.5) (8.9) (9.9) (8.5) (5.6) (0.0) (0.0)
Investing Activities
Capital Expenditure 0 0 0 (0.0) (0.0) (0.1) (0.1) (0.4) (0.3) (1.1) (0.6) (1.0) (0.8) (0.4) (0.9) (0.8) (1.0) (0.3) (0.7) (0.4) (1.0) (0.3) (0.2) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 (0.0) (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 (66.7) 0 (24.7) (9.5) (7.3) (32.0) (7.9) (5.5) (59.4) (34.1) (120.9) (7.2) (33.3) (58.8) (27.1) 0 (1.5) (260.0) 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 8.5 6.4 40.1 36.2 71.7 29.5 42.8 34.4 37 68.2 49.8 46.5 26 35.0 81.4 45.1 42.5 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 8.5 (60.3) 40.1 11.5 62.2 22.1 10.7 26.1 31.2 7.7 15.0 (75.4) 18.0 1.4 21.6 17.2 41.5 (1.8) (260.6) (0.4) (1.0) (0.3) (0.2) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 (0.1) (0.2) (0.2) (0.1) (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) (0.1) (0.1) (0.1) (0.0) 0 0
Stock Repurchased 0 0 (0.0) 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.1) (0.0) 0 (0.0) 0 (0.0) (0.0) 0.2 (0.0) 0.3 (0.0) 0 0 0 0 0 0 0 0 0 0.4 (0.0) 0.1 0.0 0 0 0 0.0 0.0
Financing Cash Flow (0.3) 24.9 (0.0) 0.0 (0.2) (0.0) (0.1) 0.1 (0.0) 25.2 0.1 111.3 (0.3) 0.2 0.1 0.4 0.2 2.0 0.7 0.4 161.8 (1.3) 217.8 (0.1) 29.8 (0.1) (0.0) 0.0 0.0
Cash Position
Net Change in Cash (13.5) (12.3) 21.0 (14.5) 27.8 1.3 (16.7) 3.1 (0.6) 9.4 (10.6) 8.2 (12.4) (21.4) 1.3 (0.9) 19.8 (29.6) (281.7) (19.9) 144.7 (16.5) 205.1 (9.0) 19.8 (8.8) (6.1) 0.0 0.0
Cash at Beginning 35.3 50.8 29.8 44.3 16.5 15.2 31.9 28.8 25.3 19.9 30.5 18.2 30.6 56.1 50.7 51.6 31.8 61.4 343.1 363.0 218.3 234.8 29.7 38.7 18.9 27.6 33.7 0.0 0
Cash at End 21.8 38.5 50.8 29.8 44.3 16.5 15.2 31.9 24.7 29.3 19.9 26.4 18.2 34.6 52.0 50.7 51.6 31.8 61.4 343.1 363.0 218.3 234.8 29.7 38.7 18.9 27.6 0.0 0.0
Free Cash Flow (21.7) 23.1 (19.1) (26.1) (34.3) (20.8) (27.4) (23.4) (32.1) (24.7) (26.3) (28.7) (30.9) (23.3) (21.4) (19.2) (22.8) (26.0) (22.4) (20.3) (17.1) (15.2) (12.7) (8.9) (10.0) (8.7) (6.1) (0.0) (0.0)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 4.6 5.6 6.5 0 0 4 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 4.2 5.6 6.5 0 0 4 3 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (14.2) (17.3) (20.4) (32.2) (34.6) (33.8) (34.4) (37.2) (34.3) (37.4) (33.4) (32.4) (29.1) (33.4) (30.4) (29.5) (30.3) (33.0) (30.8) (27.9) (22.0) (19.4) (18.1) (11.4) (9.7) (10.1) (6.9) (5.6) (5.6)
Net Income (10.4) (16.5) (19.7) (31.2) (32.1) (28.7) (32.3) (34.7) (31.4) (33.1) (30.6) (30.4) (27.7) (28.6) (30.0) (27.4) (29.5) (32.8) (30.7) (26.9) (21.3) (19.2) (16.8) (11.4) (9.5) (10.0) (6.7) (5.4) (5.4)
EPS (Diluted) -0.13 -0.26 -0.26 -0.41 -0.42 -0.38 -0.43 -0.46 -0.42 -0.48 -0.45 -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 -0.51 -0.44 -0.30 -0.29 -0.31 -0.21 -3.42 -3.42
Balance Sheet
Cash & Equivalents 21.8 35.3 47.5 25.8 40.3 12.5 11.1 27.8 24.7 25.3 15.9 26.4 18.2 30.6 52.0 50.7 51.6 31.8 61.4 343.1 363.0 218.3 234.8 29.7 0 18.9 (15.6)
Total Assets 119.6 141.3 94.8 114.9 141.3 175.5 197.2 224.3 247.1 277.7 258.5 280.6 198.3 220.5 242.3 259.1 280.7 305.1 331.2 349.6 369.8 223.6 239.7 32.7 0 21.9 0
Total Debt 17.7 17.8 17.9 17.9 17.9 18.0 18.1 18.2 17.6 16.9 0.5 0.9 1.4 1.8 1.4 1.8 2.2 1.7 2.1 1.9 2.2 0 0 0.1 0 0.3 0
Stockholders' Equity 60.2 68.6 58.5 75.8 103.2 131.5 156.4 182.3 210.7 237.1 238.3 262.1 175.3 195.4 217.4 240.8 261.8 285.9 311.2 334.4 356.6 212.2 228.3 27.1 0 (49.4) 13.9
Cash Flow
Operating Cash Flow (21.7) 23.1 (19.1) (26.1) (34.2) (20.7) (27.3) (23.1) (31.8) (23.6) (25.7) (27.7) (30.1) (22.9) (20.4) (18.5) (21.9) (25.7) (21.8) (19.9) (16.1) (14.8) (12.5) (8.9) (9.9) (8.5) (5.6) (0.0) (0.0)
Capital Expenditure 0 0 0 (0.0) (0.0) (0.1) (0.1) (0.4) (0.3) (1.1) (0.6) (1.0) (0.8) (0.4) (0.9) (0.8) (1.0) (0.3) (0.7) (0.4) (1.0) (0.3) (0.2) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0)
Free Cash Flow (21.7) 23.1 (19.1) (26.1) (34.3) (20.8) (27.4) (23.4) (32.1) (24.7) (26.3) (28.7) (30.9) (23.3) (21.4) (19.2) (22.8) (26.0) (22.4) (20.3) (17.1) (15.2) (12.7) (8.9) (10.0) (8.7) (6.1) (0.0) (0.0)